China to strengthen global cooperation in trials of Covid-19 vaccine

Published
0

BEIJING: China will strengthen international cooperation in future Covid-19 clinical vaccine trials, building on earlier collaboration in vaccine development, the science and technology minister said on Sunday.

China is expending great efforts in the global scramble to develop a vaccine for the new coronaries epidemic that began in its central city of Wuhan, with Chinese researchers conducting five separate clinical trials on humans, or half of all such trials globally, according to the data compiled by the World Health Organisation.

President Xi Jinping vowed last month at the World Heath Assembly, the WHO’s governing body, that vaccines China’s develops will become a “global public good” once they are ready for use, and it will be China’s contribution to ensuring vaccine accessibility and affordability in developing countries.

Developing “a vaccine is still the fundamental strategy in our effort to overcome the new coronavirus,” Science and Technology Minister Wang Zhigang told a news conference in Beijing.

But vaccine development is very difficult and takes time, he said, when asked how China would initially prioritise shots by country when a vaccine is found.

“The rigour of vaccine development has been compared by some scientists to a dance involving precise steps and rehearsals,” Wang said.

In a white paper unveiled by the State Council Information Office at the news conference, the government urges global cooperation, saying the international community should resist finger-pointing and politicising the virus. It did not name any country.

US President Donald Trump’s administration has accused China of cover-ups and lack of transparency regarding the pandemic. Beijing has repeatedly denied the allegations, saying it has been keeping the world informed from the start.

The head of the Chinese Centre for Disease Control and Prevention briefed his US counterpart by phone on the then-unknown virus as early as Jan 4, according to the white paper.

In the white paper, the Chinese government said the medical cost of all the coronavirus patients in China totalled 1.35 billion yuan ($191 million) as of the end of May.

President Xi last month pledged $2 billion in financial support over the next two years to help deal with Covid-19, especially to help developing countries.

Published in Dawn, June 8th, 2020

Opinion

Editorial

Fixing bond markets
Updated 01 Oct, 2026

Fixing bond markets

Pension funds, insurance companies, mutual funds, retail investors, and eventually, foreign investors must become bigger participants in the market.
Call centre rackets
01 Oct, 2026

Call centre rackets

A NUMBER of recent raids conducted by the authorities in different cities point to the growing threat fraudulent ...
Homeward bound
01 Oct, 2026

Homeward bound

FIVE months after Somali pirates captured an oil tanker carrying a 19-member multinational crew, Somali maritime...
Kashmir unresolved
Updated 30 Sep, 2026

Kashmir unresolved

The just solution lies in India addressing the issue through a trilateral dialogue involving the legitimate representatives of the Kashmiri people and Pakistan.
Water shortage
30 Sep, 2026

Water shortage

THAT the country is entering the Rabi season with an anticipated water shortage of nearly 25pc, the lowest carryover...
Young hearts
30 Sep, 2026

Young hearts

THE observance may have passed, but the message of World Heart Day should not fade with it. The occasion is a useful...